Arch Therapeutics Inc (ARTH)

[Regis999]

Arch Therapeutics (ARTH)


Anytime a hole in the body occurs one needs to worry about bleeding, leaking and contamination to mitigate infection. Arch’s AC5 to address these needs. Arch intends to transform the landscape of interventional healthcare with products to seal and protect leaking and bleeding tissue.

The Company has identified over 200 potential areas where AC5 could be used including: Surgery, Trauma Care, Wound Care, Military, Adhesions, Pressure Ulcers (Bedsores) (2.5 million cases in USA with annual cost $ 10 billion), Foot Ulcers, Burns, etc.

Human Clinical Trials have begun in Ireland. Total Europe and USA trial cost estimated to be $10 to $14 million.


The CEO is a MD, MIT MBA and Former Portfolio Manager at Putnam $4 Billion Healthcare Fund


Arch Therapuetic AC5 Surgical Hemostatic Device


Synthetic peptide


Clear liquid, squirted or sprayed-- Can see and operate through it

Conforms to irregular wound geometry
Physical mechanical barrier (no metabolic activity or chemical activity with the body)

Classified as Medical Device in Europe because of no interaction with the body
No sign of interaction with human cell receptors or cell kinase enzymes

Stops bleeding promptly

Faster time to stop bleeding versus five different popular marketed products

Blood thinner agnostic—only hemostasis product that is.

Efficacy even in presence of “blood thinners”
Bioasborbable

Natural amino acids, non-animal

Enables normal healing

Non-cytotoxic, non-pyrogenic, non-irritant, non-sensitizer

Stores at room temperature

Indefinite shelf life

Simple, effective, versatile, safe universal



There are many other hemostatic agents, but:

* They all rely on using the patient's blood,

*They all take minutes to stop bleeding, not seconds

* None of them create a clear seal that a surgeon can see through

* None of them work just as well on people on blood thinners

* None of them work in every situation where bleeding has to be stopped

Arch's AC5 product solves all these problems